Stockreport

Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate (ADC) [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF Multiple Solid Tumor Settings to Be Pursued with Clinical Trials Expected to Start in Mid-2026 MIAMI, January 12, 2026 BUSINESS WIRE )--Summit Therapeutics Inc. (NASD [Read more]